Appearance and disappearance of neutralizing antibodies during interferon-beta therapy

P Soelberg Sorensen; Nils Koch-Henriksen; C Ross; K M Clemmesen; K Bendtzen; Danish Multiple Sclerosis Study Group

doi:10.1212/01.WNL.0000166049.51502.6A

Appearance and disappearance of neutralizing antibodies during interferon-beta therapy

P Soelberg Sorensen, Nils Koch-Henriksen, C Ross, K M Clemmesen, K Bendtzen, Danish Multiple Sclerosis Study Group

170 Citationer (Scopus)

Abstract

Neutralizing antibodies (NABs) occur frequently in patients receiving interferon (IFN)-beta for multiple sclerosis (MS), but it is unclear whether occurrence of NABs is predictive for the persistence of NABs during continued IFN-beta therapy.

Originalsprog	Engelsk
Tidsskrift	Neurology
Vol/bind	65
Udgave nummer	1
Sider (fra-til)	33-9
Antal sider	7
ISSN	0028-3878
DOI	https://doi.org/10.1212/01.WNL.0000166049.51502.6A
Status	Udgivet - 12 jul. 2005

Adgang til dokumentet

10.1212/01.WNL.0000166049.51502.6A

Citationsformater

@article{fcea211250304d0eb8334c3f0eb4d5b9,

title = "Appearance and disappearance of neutralizing antibodies during interferon-beta therapy",

abstract = "Neutralizing antibodies (NABs) occur frequently in patients receiving interferon (IFN)-beta for multiple sclerosis (MS), but it is unclear whether occurrence of NABs is predictive for the persistence of NABs during continued IFN-beta therapy.",

author = "Sorensen, {P Soelberg} and Nils Koch-Henriksen and C Ross and Clemmesen, {K M} and K Bendtzen and Clemmesen, {Katja Maria}",

year = "2005",

month = jul,

day = "12",

doi = "10.1212/01.WNL.0000166049.51502.6A",

language = "English",

volume = "65",

pages = "33--9",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams & Wilkins",

number = "1",

}

TY - JOUR

T1 - Appearance and disappearance of neutralizing antibodies during interferon-beta therapy

AU - Sorensen, P Soelberg

AU - Koch-Henriksen, Nils

AU - Ross, C

AU - Clemmesen, K M

AU - Bendtzen, K

AU - Danish Multiple Sclerosis Study Group

PY - 2005/7/12

Y1 - 2005/7/12

N2 - Neutralizing antibodies (NABs) occur frequently in patients receiving interferon (IFN)-beta for multiple sclerosis (MS), but it is unclear whether occurrence of NABs is predictive for the persistence of NABs during continued IFN-beta therapy.

AB - Neutralizing antibodies (NABs) occur frequently in patients receiving interferon (IFN)-beta for multiple sclerosis (MS), but it is unclear whether occurrence of NABs is predictive for the persistence of NABs during continued IFN-beta therapy.

U2 - 10.1212/01.WNL.0000166049.51502.6A

DO - 10.1212/01.WNL.0000166049.51502.6A

M3 - Journal article

SN - 0028-3878

VL - 65

SP - 33

EP - 39

JO - Neurology

JF - Neurology

IS - 1

ER -

Appearance and disappearance of neutralizing antibodies during interferon-beta therapy

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater